Nirmatrelvir for vaccinated or unvaccinated adult outpatients with Covid-19

J Hammond, RJ Fountaine, C Yunis… - … England Journal of …, 2024 - Mass Medical Soc
Background Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-
moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients …
被引用次数：10 相关文章
[PDF] colmedicosantafe2.org.ar

[PDF][PDF] Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid

J Hammond, RJ Fountaine, W Bao, W Wisemandle… - colmedicosantafe2.org.ar
BACKGROUND Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-
moderate coronavirus disease (Covid-). The efficacy of this treatment in patients who are at …

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

J Hammond, RJ Fountaine, C Yunis… - The New England …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-
moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients …

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.

J Hammond, RJ Fountaine, C Yunis… - The New England …, 2024 - europepmc.org
Background Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-
moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients …
[PDF] researchgate.net

[PDF][PDF] Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

C Yunis, BSN Dona Fleishaker, M Almas, W Bao… - N Engl J …, 2024 - researchgate.net
BACKGROUND Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-
tomoderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients …
[PDF] broomedocs.com

[PDF][PDF] Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

C Yunis, BSN Dona Fleishaker, M Almas, W Bao… - N Engl J …, 2024 - broomedocs.com
BACKGROUND Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-
tomoderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients …